Irinotecan in Colorectal Cancer Research: Next-Gen Workfl...

2025-10-18

Irinotecan (CPT-11) is powering a new era of colorectal cancer research by enabling physiologically relevant DNA damage and apoptosis studies within advanced assembloid models. This guide delivers actionable protocols, troubleshooting strategies, and expert insights for maximizing Irinotecan’s impact in tumor–stroma interaction studies and translational pipelines.